Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
74.38
-0.11 (-0.15%)
Sep 29, 2026, 10:49 AM EDT - Market open
Utah Medical Products Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 237 | 179 | 208 | 306 | 365 | 365 | |
Market Cap Growth | 17.52% | -14.01% | -31.80% | -16.18% | -0.11% | 18.97% |
Enterprise Value | 149 | 95 | 120 | 218 | 296 | 301 |
Last Close Price | 74.49 | 55.20 | 59.36 | 79.88 | 94.09 | 92.37 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.70 | 15.89 | 15.03 | 18.38 | 22.14 | 24.69 |
Forward PE | - | 17.80 | 17.80 | 17.80 | 17.80 | 17.80 |
PS Ratio | 6.56 | 4.65 | 5.10 | 6.09 | 6.98 | 7.44 |
PB Ratio | 1.94 | 1.50 | 1.78 | 2.38 | 3.19 | 3.41 |
P/TBV Ratio | 2.20 | 1.72 | 2.07 | 2.79 | 4.03 | 4.85 |
P/FCF Ratio | 20.70 | 12.52 | 14.28 | 14.12 | 17.93 | 17.68 |
P/OCF Ratio | 20.00 | 12.20 | 14.06 | 13.72 | 17.25 | 17.22 |
PEG Ratio | - | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.14 | 2.47 | 2.94 | 4.34 | 5.65 | 6.14 |
EV/EBITDA Ratio | 10.41 | 6.06 | 6.49 | 9.43 | 11.02 | 11.51 |
EV/EBIT Ratio | 12.50 | 7.47 | 7.65 | 12.98 | 14.93 | 15.95 |
EV/FCF Ratio | 13.07 | 6.65 | 8.24 | 10.06 | 14.53 | 14.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
Debt / FCF Ratio | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
Net Debt / Equity Ratio | -0.72 | -0.72 | -0.70 | -0.72 | -0.65 | -0.56 |
Net Debt / EBITDA Ratio | -6.08 | -5.44 | -4.46 | -4.01 | -2.79 | -2.32 |
Net Debt / FCF Ratio | -7.63 | -5.97 | -5.66 | -4.28 | -3.67 | -2.93 |
Asset Turnover | 0.29 | 0.31 | 0.32 | 0.39 | 0.44 | 0.43 |
Inventory Turnover | 1.76 | 1.97 | 1.82 | 2.19 | 2.61 | 2.83 |
Quick Ratio | 44.01 | 34.36 | 23.18 | 20.44 | 13.52 | 17.65 |
Current Ratio | 48.62 | 37.62 | 25.64 | 22.56 | 15.09 | 19.54 |
Return on Equity (ROE) | 8.76% | 9.54% | 11.29% | 13.72% | 14.88% | 14.09% |
Return on Assets (ROA) | 6.10% | 6.51% | 7.62% | 8.09% | 10.33% | 10.38% |
Return on Invested Capital (ROIC) | 28.71% | 29.78% | 36.87% | 36.91% | 36.65% | 29.85% |
Return on Capital Employed (ROCE) | 9.80% | 10.60% | 13.20% | 12.80% | 16.80% | 16.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.43% | 6.30% | 6.65% | 5.44% | 4.52% | 4.05% |
FCF Yield | 4.83% | 7.99% | 7.00% | 7.08% | 5.58% | 5.66% |
Dividend Yield | 1.67% | 2.22% | 2.03% | 1.48% | 1.24% | 0.93% |
Payout Ratio | 37.78% | 35.29% | 30.70% | 25.74% | 19.20% | 77.53% |
Buyback Yield / Dilution | 4.75% | 7.51% | 3.68% | 0.17% | 0.46% | 0.33% |
Total Shareholder Return | 6.42% | 9.73% | 5.71% | 1.65% | 1.70% | 1.25% |